In September 2020, Kos designed, developed, and implemented the Cidala Patient Program. Arrotex Pharmaceuticals (Arrotex) partnered with PharmaPrograms to promote the Cidala Patient Program through community pharmacies. The Cidala Patient Program (Program) supports patients prescribed Tadalafil and dispensed as Cidala (tadalafil) tablets.
The Program aims to improve medication compliance and adherence, by facilitating communication between pharmacists and patients. This is a private prescription-only medicine used to treat erectile dysfunction (impotence) and symptoms of benign prostatic hypertrophy (enlarged prostate).